Seroepidemiology of diphtheria and tetanus among children and young adults in Tajikistan: nationwide population-based survey, 2010. 2013

Nino Khetsuriani, and Katherina Zakikhany, and Shamsiddin Jabirov, and Nargis Saparova, and Pavel Ursu, and Kathleen Wannemuehler, and Steve Wassilak, and Androulla Efstratiou, and Rebecca Martin
Centers for Disease Control and Prevention (CDC), Atlanta, United States. Electronic address: nck7@cdc.gov.

BACKGROUND Tajikistan had a major diphtheria outbreak (≈ 10,000 cases) in the 1990 s, which was controlled after nationwide immunization campaigns with diphtheria-tetanus toxoid in 1995 and 1996. Since 2000, only 52 diphtheria cases have been reported. However, in coverage surveys conducted in 2000 and 2005, diphtheria-tetanus-pertussis vaccine coverage was lower than administratively reported estimates raising concerns about potential immunity gaps. To further assess population immunity to diphtheria in Tajikistan, diphtheria antibody testing was included in a large-scale nationwide serosurvey for vaccine-preventable diseases conducted in connection with a poliomyelitis outbreak in 2010. In addition, the serosurvey provided an opportunity to assess population immunity to tetanus. METHODS Residents of all regions of Tajikistan aged 1-24 years were included in the serosurvey implemented during September-October 2010. Participants were selected through stratified cluster sampling. Specimens were tested for diphtheria antibodies using a Vero cell neutralization assay and for tetanus antibodies using an anti-tetanus IgG ELISA. Antibody concentrations ≥ 0.1 IU/mL were considered seropositive. RESULTS Overall, 51.4% (95% CI, 47.1%-55.6%) of participants were seropositive for diphtheria and 78.9% (95% CI, 74.7%-82.5%) were seropositive for tetanus. The lowest percentages of seropositivity for both diseases were observed among persons aged 10-19 years: diphtheria seropositivity was 37.1% (95% CI, 31.0%-43.7%) among 10-14 year-olds, and 35.3% (95% CI, 29.9%-41.1%) among 15-19 year-olds; tetanus seropositivity in respective age groups was 65.3% (95% CI, 58.4%-71.6%) and 70.1% (95% CI, 64.5%-75.2%). CONCLUSIONS Population immunity for diphtheria in Tajikistan is low, particularly among 10-19 year-olds. Population immunity to tetanus is generally higher than for diphtheria, but is suboptimal among 10-19 year-olds. These findings highlight the need to improve routine immunization service delivery, and support a one-time supplementary immunization campaign with diphtheria-tetanus toxoid among birth cohorts aged 1-19 years in 2010 (3-21 years in 2012) to close immunity gaps and prevent diphtheria outbreaks.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004165 Diphtheria A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects. Corynebacterium diphtheriae Infection,Corynebacterium diphtheriae Infections,Infection, Corynebacterium diphtheriae
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Nino Khetsuriani, and Katherina Zakikhany, and Shamsiddin Jabirov, and Nargis Saparova, and Pavel Ursu, and Kathleen Wannemuehler, and Steve Wassilak, and Androulla Efstratiou, and Rebecca Martin
March 2022, Vaccine,
Nino Khetsuriani, and Katherina Zakikhany, and Shamsiddin Jabirov, and Nargis Saparova, and Pavel Ursu, and Kathleen Wannemuehler, and Steve Wassilak, and Androulla Efstratiou, and Rebecca Martin
July 1988, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Nino Khetsuriani, and Katherina Zakikhany, and Shamsiddin Jabirov, and Nargis Saparova, and Pavel Ursu, and Kathleen Wannemuehler, and Steve Wassilak, and Androulla Efstratiou, and Rebecca Martin
January 1988, Nuovi annali d'igiene e microbiologia,
Nino Khetsuriani, and Katherina Zakikhany, and Shamsiddin Jabirov, and Nargis Saparova, and Pavel Ursu, and Kathleen Wannemuehler, and Steve Wassilak, and Androulla Efstratiou, and Rebecca Martin
July 2009, Japanese journal of infectious diseases,
Nino Khetsuriani, and Katherina Zakikhany, and Shamsiddin Jabirov, and Nargis Saparova, and Pavel Ursu, and Kathleen Wannemuehler, and Steve Wassilak, and Androulla Efstratiou, and Rebecca Martin
October 1981, Deutsche medizinische Wochenschrift (1946),
Nino Khetsuriani, and Katherina Zakikhany, and Shamsiddin Jabirov, and Nargis Saparova, and Pavel Ursu, and Kathleen Wannemuehler, and Steve Wassilak, and Androulla Efstratiou, and Rebecca Martin
April 2024, Vaccines,
Nino Khetsuriani, and Katherina Zakikhany, and Shamsiddin Jabirov, and Nargis Saparova, and Pavel Ursu, and Kathleen Wannemuehler, and Steve Wassilak, and Androulla Efstratiou, and Rebecca Martin
January 2018, The Journal of the Association of Nurses in AIDS Care : JANAC,
Nino Khetsuriani, and Katherina Zakikhany, and Shamsiddin Jabirov, and Nargis Saparova, and Pavel Ursu, and Kathleen Wannemuehler, and Steve Wassilak, and Androulla Efstratiou, and Rebecca Martin
March 1993, The Journal of communicable diseases,
Nino Khetsuriani, and Katherina Zakikhany, and Shamsiddin Jabirov, and Nargis Saparova, and Pavel Ursu, and Kathleen Wannemuehler, and Steve Wassilak, and Androulla Efstratiou, and Rebecca Martin
June 2007, Pediatrics international : official journal of the Japan Pediatric Society,
Nino Khetsuriani, and Katherina Zakikhany, and Shamsiddin Jabirov, and Nargis Saparova, and Pavel Ursu, and Kathleen Wannemuehler, and Steve Wassilak, and Androulla Efstratiou, and Rebecca Martin
January 2016, PloS one,
Copied contents to your clipboard!